Literature DB >> 22511778

DiGeorge syndrome critical region 8 (DGCR8) protein-mediated microRNA biogenesis is essential for vascular smooth muscle cell development in mice.

Zixuan Chen1, Jianmin Wu, Chuanhe Yang, Pei Fan, Louisa Balazs, Yan Jiao, Meifeng Lu, Weikuan Gu, Chengyao Li, Lawrence M Pfeffer, Gabor Tigyi, Junming Yue.   

Abstract

DiGeorge Critical Region 8 (DGCR8) is a double-stranded RNA-binding protein that interacts with Drosha and facilitates microRNA (miRNA) maturation. However, the role of DGCR8 in vascular smooth muscle cells (VSMCs) is not well understood. To investigate whether DGCR8 contributes to miRNA maturation in VSMCs, we generated DGCR8 conditional knockout (cKO) mice by crossing VSMC-specific Cre mice (SM22-Cre) with DGCR8(loxp/loxp) mice. We found that loss of DGCR8 in VSMCs resulted in extensive liver hemorrhage and embryonic mortality between embryonic days (E) 12.5 and E13.5. DGCR8 cKO embryos displayed dilated blood vessels and disarrayed vascular architecture. Blood vessels were absent in the yolk sac of DGCR8 KOs after E12.5. Disruption of DGCR8 in VSMCs reduced VSMC proliferation and promoted apoptosis in vitro and in vivo. In DGCR8 cKO embryos and knockout VSMCs, differentiation marker genes, including αSMA, SM22, and CNN1, were significantly down-regulated, and the survival pathways of ERK1/2 mitogen-activated protein kinase and the phosphatidylinositol 3-kinase/AKT were attenuated. Knockout of DGCR8 in VSMCs has led to down-regulation of the miR-17/92 and miR-143/145 clusters. We further demonstrated that the miR-17/92 cluster promotes VSMC proliferation and enhances VSMC marker gene expression, which may contribute to the defects of DGCR8 cKO mutants. Our results indicate that the DGCR8 gene is required for vascular development through the regulation of VSMC proliferation, apoptosis, and differentiation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22511778      PMCID: PMC3365935          DOI: 10.1074/jbc.M112.351791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  miR-143 and miR-145: molecular keys to switch the phenotype of vascular smooth muscle cells.

Authors:  Ashraf Yusuf Rangrez; Ziad A Massy; Valérie Metzinger-Le Meuth; Laurent Metzinger
Journal:  Circ Cardiovasc Genet       Date:  2011-04

2.  Implication of microRNAs in atrial natriuretic peptide and nitric oxide signaling in vascular smooth muscle cells.

Authors:  Kumar U Kotlo; Bahar Hesabi; Robert S Danziger
Journal:  Am J Physiol Cell Physiol       Date:  2011-07-06       Impact factor: 4.249

3.  Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region.

Authors:  Aiko Shiohama; Takashi Sasaki; Setsuko Noda; Shinsei Minoshima; Nobuyoshi Shimizu
Journal:  Biochem Biophys Res Commun       Date:  2003-04-25       Impact factor: 3.575

4.  A role for noncanonical microRNAs in the mammalian brain revealed by phenotypic differences in Dgcr8 versus Dicer1 knockouts and small RNA sequencing.

Authors:  Joshua E Babiarz; Ruby Hsu; Collin Melton; Molly Thomas; Erik M Ullian; Robert Blelloch
Journal:  RNA       Date:  2011-06-28       Impact factor: 4.942

5.  Bone morphogenetic protein 4 promotes vascular smooth muscle contractility by activating microRNA-21 (miR-21), which down-regulates expression of family of dedicator of cytokinesis (DOCK) proteins.

Authors:  Hara Kang; Brandi N Davis-Dusenbery; Peter H Nguyen; Ashish Lal; Judy Lieberman; Linda Van Aelst; Giorgio Lagna; Akiko Hata
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

6.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.

Authors:  Rita Holtwick; Michael Gotthardt; Boris Skryabin; Martin Steinmetz; Regine Potthast; Bernd Zetsche; Robert E Hammer; Joachim Herz; Michaela Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

7.  Embryonic lineage of vascular smooth muscle cells determines responses to collagen matrices and integrin receptor expression.

Authors:  S L Thieszen; M Dalton; P F Gadson; E Patterson; T H Rosenquist
Journal:  Exp Cell Res       Date:  1996-08-25       Impact factor: 3.905

Review 8.  miRNA and vascular cell movement.

Authors:  Junming Yue
Journal:  Adv Drug Deliv Rev       Date:  2011-01-15       Impact factor: 15.470

9.  Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination.

Authors:  Boris V Skryabin; Rita Holtwick; Larissa Fabritz; Markus N Kruse; Ilka Veltrup; Jörg Stypmann; Paulus Kirchhof; Karim Sabrane; Alexander Bubikat; Melanie Voss; Michaela Kuhn
Journal:  Genesis       Date:  2004-08       Impact factor: 2.487

10.  MicroRNAs dynamically remodel gastrointestinal smooth muscle cells.

Authors:  Chanjae Park; Wei Yan; Sean M Ward; Sung Jin Hwang; Qiuxia Wu; William J Hatton; Jong Kun Park; Kenton M Sanders; Seungil Ro
Journal:  PLoS One       Date:  2011-04-14       Impact factor: 3.240

View more
  30 in total

Review 1.  Mechanisms and therapeutic potential of microRNAs in hypertension.

Authors:  Lijun Shi; Jingwen Liao; Bailin Liu; Fanxing Zeng; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-05-21       Impact factor: 7.851

Review 2.  The short and long of noncoding sequences in the control of vascular cell phenotypes.

Authors:  Joseph M Miano; Xiaochun Long
Journal:  Cell Mol Life Sci       Date:  2015-05-29       Impact factor: 9.261

Review 3.  MicroRNA in intervertebral disc degeneration.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2015-03-04       Impact factor: 6.831

Review 4.  Dgcr8 knockout approaches to understand microRNA functions in vitro and in vivo.

Authors:  Wen-Ting Guo; Yangming Wang
Journal:  Cell Mol Life Sci       Date:  2019-01-29       Impact factor: 9.261

Review 5.  Genetic syndromes caused by mutations in epigenetic genes.

Authors:  María Berdasco; Manel Esteller
Journal:  Hum Genet       Date:  2013-01-31       Impact factor: 4.132

6.  Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.

Authors:  Laura S Danielson; David S Park; Noemi Rotllan; Aranzazu Chamorro-Jorganes; Maria V Guijarro; Carlos Fernandez-Hernando; Glenn I Fishman; Colin K L Phoon; Eva Hernando
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

7.  Optogenetic approach for functional assays of the cardiovascular system by light activation of the vascular smooth muscle.

Authors:  Yang Wu; Shan-Shan Li; Xin Jin; Ningren Cui; Shuang Zhang; Chun Jiang
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

Review 8.  MicroRNA expression and its clinical implications in Ewing's sarcoma.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen; William Ka Kei Wu; Matthew T V Chan
Journal:  Cell Prolif       Date:  2014-12-22       Impact factor: 6.831

9.  Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Authors:  Minati Singh
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

Review 10.  The roles of microRNAs and protein components of the microRNA pathway in lung development and diseases.

Authors:  Leah Cushing; Zhihua Jiang; Pingping Kuang; Jining Lü
Journal:  Am J Respir Cell Mol Biol       Date:  2015-04       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.